Applied DNA Sciences (APDN) Jumps 32% In Strong Day For PRISM Vaccines and Cell Therapy Index
Applied DNA Sciences (APDN) jumped 32%, surging very quickly at around 11:30 AM EST. It is unclear exactly why APDN surged in that moment as there were no new press releases.
The latest press release is two weeks ago, when APDN released full-year 2022 earnings, beating EPS expectations, but with lagging revenues.
The large gains come alongside a strong day for the PRISM Vaccines and Cell Therapy Index, which rose 3.2% for the day, leading all PRISM Indexes. This is largely due to APDN, but also TFF Pharmaceuticals (TFFP) which rose 25% for the day.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using PCR to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the ticker symbol ‘APDN,’ and its publicly traded warrants are listed on OTC under the ticker symbol ‘APPDW.’